QWP
ABBV icon

Quotient Wealth Partners’s AbbVie ABBV Stock Holding History

Quotient Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
10,682
+239
+2% +$51.4K 0.06% 78
2026
Q1 		$2.27M Buy
10,443
+192
+2% +$42.6K 0.06% 78
2025
Q4 		$2.34M Buy
10,251
+2,052
+25% +$467K 0.06% 77
2025
Q3 		$1.9M Sell
8,199
-22
-0.3% -$4.48K 0.05% 85
2025
Q2 		$1.53M Buy
8,221
+337
+4% +$62.6K 0.04% 93
2025
Q1 		$1.65M Buy
7,884
+702
+10% +$136K 0.05% 82
2024
Q4 		$1.28M Buy
7,182
+902
+14% +$166K 0.04% 88
2024
Q3 		$1.24M Sell
6,280
-453
-7% -$84.5K 0.04% 89
2024
Q2 		$1.15M Buy
6,733
+697
+12% +$115K 0.04% 94
2024
Q1 		$1.1M Buy
6,036
+2
+0% +$345 0.04% 106
2023
Q4 		$935K Buy
+6,034
New +$880K 0.04% 124

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quotient Wealth Partners's ABBV Position: Q2 2026 in Review

Quotient Wealth Partners increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $51.4K and bringing the position to 10,682 shares worth $2.69M. The position accounts for 0.06% of the portfolio, ranked #78.

Quotient Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Quotient Wealth Partners held 10,682 shares of AbbVie worth $2.69M as of Q2 2026.
  • Quotient Wealth Partners bought 239 AbbVie shares in Q2 2026, an estimated $51.4K.
  • AbbVie made up 0.06% of Quotient Wealth Partners's portfolio in Q2 2026, its #78 holding.
  • Quotient Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.